159 related articles for article (PubMed ID: 19691472)
1. High-content analysis of cancer-cell-specific apoptosis and inhibition of in vivo angiogenesis by synthetic (-)-pironetin and analogs.
Vogt A; McPherson PA; Shen X; Balachandran R; Zhu G; Raccor BS; Nelson SG; Tsang M; Day BW
Chem Biol Drug Des; 2009 Oct; 74(4):358-68. PubMed ID: 19691472
[TBL] [Abstract][Full Text] [Related]
2. Antiproliferating activity of the mitotic inhibitor pironetin against vindesine- and paclitaxel-resistant human small cell lung cancer H69 cells.
Yoshida M; Matsui Y; Ikarashi Y; Usui T; Osada H; Wakasugi H
Anticancer Res; 2007; 27(2):729-36. PubMed ID: 17465195
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Cytotoxicity Evaluation of C4- and C5-Modified Analogues of the α,β-Unsaturated Lactone of Pironetin.
Huang DS; Wong HL; Georg GI
ChemMedChem; 2017 Apr; 12(7):520-528. PubMed ID: 28261964
[TBL] [Abstract][Full Text] [Related]
4. A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos.
Vollmer LL; Jiménez M; Camarco DP; Zhu W; Daghestani HN; Balachandran R; Reese CE; Lazo JS; Hukriede NA; Curran DP; Day BW; Vogt A
Mol Cancer Ther; 2011 Jun; 10(6):994-1006. PubMed ID: 21490306
[TBL] [Abstract][Full Text] [Related]
5. The anticancer natural product pironetin selectively targets Lys352 of alpha-tubulin.
Usui T; Watanabe H; Nakayama H; Tada Y; Kanoh N; Kondoh M; Asao T; Takio K; Watanabe H; Nishikawa K; Kitahara T; Osada H
Chem Biol; 2004 Jun; 11(6):799-806. PubMed ID: 15217613
[TBL] [Abstract][Full Text] [Related]
6. Revisiting microtubule targeting agents: α-Tubulin and the pironetin binding site as unexplored targets for cancer therapeutics.
Coulup SK; Georg GI
Bioorg Med Chem Lett; 2019 Aug; 29(15):1865-1873. PubMed ID: 31130264
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of truncated α-tubulin-binding pironetin analogues lacking alkyl pendants in the side chain or the dihydropyrone ring.
Paños J; Díaz-Oltra S; Sánchez-Peris M; García-Pla J; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Org Biomol Chem; 2013 Sep; 11(35):5809-26. PubMed ID: 23892508
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of C2 functionalized analogs of the α-tubulin-binding natural product pironetin.
Huang DS; Wong HL; Georg GI
Bioorg Med Chem Lett; 2018 Sep; 28(16):2789-2793. PubMed ID: 29138028
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin.
Kondoh M; Usui T; Nishikiori T; Mayumi T; Osada H
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):411-6. PubMed ID: 10333483
[TBL] [Abstract][Full Text] [Related]
10. The Mechanism of the Interactions of Pironetin Analog/Combretastatin A-4 Hybrids with Tubulin.
Torijano-Gutiérrez S; Vilanova C; Díaz-Oltra S; Murga J; Falomir E; Carda M; Redondo-Horcajo M; Díaz JF; Barasoain I; Marco JA
Arch Pharm (Weinheim); 2015 Aug; 348(8):541-7. PubMed ID: 26085125
[TBL] [Abstract][Full Text] [Related]
11. Pironetin Binds Covalently to αCys316 and Perturbs a Major Loop and Helix of α-Tubulin to Inhibit Microtubule Formation.
Prota AE; Setter J; Waight AB; Bargsten K; Murga J; Diaz JF; Steinmetz MO
J Mol Biol; 2016 Jul; 428(15):2981-8. PubMed ID: 27395016
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluations of new analogs of 2-methoxyestradiol: inhibitors of tubulin and angiogenesis.
Solum EJ; Cheng JJ; Sørvik IB; Paulsen RE; Vik A; Hansen TV
Eur J Med Chem; 2014 Oct; 85():391-8. PubMed ID: 25108078
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of pironetin analogues with simplified structure and study of their interactions with microtubules.
Marco JA; García-Pla J; Carda M; Murga J; Falomir E; Trigili C; Notararigo S; Díaz JF; Barasoain I
Eur J Med Chem; 2011 May; 46(5):1630-7. PubMed ID: 21396747
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of simplified pironetin analogues with modifications in the side chain and the lactone ring.
Roldán S; Cardona A; Conesa L; Murga J; Falomir E; Carda M; Marco JA
Org Biomol Chem; 2016 Dec; 15(1):220-232. PubMed ID: 27901163
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of pironetin and related analogs: studies on structure-activity relationships as tubulin assembly inhibitors.
Watanabe H; Watanabe H; Usui T; Kondoh M; Osada H; Kitahara T
J Antibiot (Tokyo); 2000 May; 53(5):540-5. PubMed ID: 10908119
[TBL] [Abstract][Full Text] [Related]
16. The design, synthesis and biological evaluation of conformationally restricted 4-substituted-2,6-dimethylfuro[2,3-d]pyrimidines as multi-targeted receptor tyrosine kinase and microtubule inhibitors as potential antitumor agents.
Zhang X; Raghavan S; Ihnat M; Hamel E; Zammiello C; Bastian A; Mooberry SL; Gangjee A
Bioorg Med Chem; 2015 May; 23(10):2408-23. PubMed ID: 25882519
[TBL] [Abstract][Full Text] [Related]
17. Pironetin reacts covalently with cysteine-316 of α-tubulin to destabilize microtubule.
Yang J; Wang Y; Wang T; Jiang J; Botting CH; Liu H; Chen Q; Yang J; Naismith JH; Zhu X; Chen L
Nat Commun; 2016 Jun; 7():12103. PubMed ID: 27357539
[TBL] [Abstract][Full Text] [Related]
18. Identification of the Metabolic Profile of the α-Tubulin-Binding Natural Product (-)-Pironetin.
Coulup SK; Huang DS; Wong HL; Georg GI
J Med Chem; 2019 Feb; 62(3):1684-1689. PubMed ID: 30693770
[TBL] [Abstract][Full Text] [Related]
19. 4-(3-Halo/amino-4,5-dimethoxyphenyl)-5-aryloxazoles and -N-methylimidazoles that are cytotoxic against combretastatin A resistant tumor cells and vascular disrupting in a cisplatin resistant germ cell tumor model.
Schobert R; Biersack B; Dietrich A; Effenberger K; Knauer S; Mueller T
J Med Chem; 2010 Sep; 53(18):6595-602. PubMed ID: 20731355
[TBL] [Abstract][Full Text] [Related]
20. Catalytic asymmetric assembly of stereodefined propionate units: an enantioselective total synthesis of (-)-pironetin.
Shen X; Wasmuth AS; Zhao J; Zhu C; Nelson SG
J Am Chem Soc; 2006 Jun; 128(23):7438-9. PubMed ID: 16756287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
